| |
| |
|
| Insider
Information: |
Mccormick Frank |
| Relationship: |
Director |
| City: |
S San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
663,489 |
|
|
Indirect Shares
|
711,949 |
|
|
| Direct
Value |
$13,127,329 |
|
|
|
Indirect Value
|
$17,443,477 |
|
|
| Total
Shares |
1,375,438 |
|
|
| Total
Value |
$30,570,806 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 29.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
|
|
0 |
|
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
|
|
0 |
|
0 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2023-12-26 |
472,376 |
2023-12-26 |
627,689 |
Premium* |
|
|
Olema Pharmaceuticals, Inc. |
OLMA |
Director |
2020-11-23 |
191,113 |
2020-11-23 |
84,260 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-12-26 |
4 |
AS |
$42.06 |
$4,206,000 |
I/I |
(100,000) |
627,689 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,200,065 |
|
% |
|
| OLMA |
Olema Pharmaceuticals, In... |
Director |
– • – |
2020-11-23 |
4 |
A |
$0.00 |
$0 |
I/I |
66,326 |
84,260 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
Director |
– • – |
2020-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
152,891 |
191,113 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
Director |
– • – |
2020-11-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,934 |
|
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
Director |
– • – |
2020-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
38,222 |
|
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Oncology |
• – – |
2020-11-13 |
4 |
S |
$42.22 |
$4,275,769 |
D/D |
(100,000) |
1,200,468 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Oncology |
• – – |
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
39,042 |
1,300,568 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Oncology |
• – – |
2019-12-30 |
4 |
AS |
$35.74 |
$614,012 |
D/D |
(17,150) |
1,261,526 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Oncology |
• – – |
2019-12-27 |
4 |
AS |
$36.37 |
$3,141,368 |
D/D |
(82,850) |
1,278,576 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Oncology |
• – – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,361,426 |
1,361,426 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
